Skip to main content
FinSpry Logo
FinSpry
NVS logo
NVS
(NYSE)
Novartis AG
$137.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Novartis (NVS) Stock Price & Financial Analysis

Novartis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$137.30 - $139.45
52-Week High$170.46
52-Week Low$121.57
Open$138.14
Volume2.93M
Average Volume (3M)1.99M
Market Cap263.14B
Shares Outstanding1.91B
P/E Ratio (TTM)20.63
Forward P/E22.20
Price to Sales (P/S)4.64
Price to Book (P/B)6.27
EV/EBITDA13.50
Revenue (TTM)56.69B
Net Income (TTM)12.76B
Free Cash Flow (TTM)15.82B
EPS (TTM)$6.63
Profit Margin22.50%
Operating Margin30.17%
Return on Equity (ROE)30.41%
Debt to Equity1.12
50-Day MA$154.87
200-Day MA$149.82
52-Week Change7.36%
Annual Dividend$4.77
Dividend Yield3.47%
Payout Ratio72.01%
Last Dividend Ex-DateMar 11, 2026

Frequently Asked Questions About Novartis

What is the current stock price for NVS?

As of the latest trading session, NVS stock trades at $137.48. The 52-week range is $121.57–$170.46, with a day range of $137.30–$139.45.

What is the P/E ratio for NVS?

Novartis's trailing P/E ratio is 20.6, meaning investors pay $20.6 for every $1 of annual earnings. The forward P/E is 22.2, reflecting analyst expectations for future earnings. Novartis operates in the Healthcare sector.

Does NVS pay dividends?

Yes, Novartis pays a 3.47% annual dividend yield ($4.77 per share). The payout ratio is 72.0%. The last ex-dividend date was 2026-03-11.

What do analysts recommend for NVS?

Based on 6 analysts, the consensus for NVS is Buy.

What is the market cap of NVS?

Novartis's market capitalization is $263.14B, classifying it as a mega-cap company. Novartis operates in the Healthcare sector within the Drug Manufacturers - General industry.